CoChat

Targeting STING with covalent small-molecule inhibitors

Open access

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Aberrant activation of innate immune pathways is associated with a variety of diseases. Progress in understanding the molecular mechanisms of innate immune pathways has led to the promise of targeted therapeutic approaches, but the development of drugs that act specifically on molecules of interest remains challenging. Here we report the discovery and characterization of highly potent and selective small-molecule antagonists of the stimulator of interferon genes (STING) protein, which is a central signalling component of the intracellular DNA sensing pathway 1,2 . Mechanistically, the identified compounds covalently target the predicted transmembrane cysteine residue 91 and thereby block the activation-induced palmitoylation of STING. Using these inhibitors, we show that the palmitoylation of STING is essential for its assembly into multimeric complexes at the Golgi apparatus and, in turn, for the recruitment of downstream signalling factors. The identified compounds and their derivatives reduce STING-mediated inflammatory cytokine production in both human and mouse cells. Furthermore, we show that these small-molecule antagonists attenuate pathological features of autoinflammatory disease in mice. In summary, our work uncovers a mechanism by which STING can be inhibited pharmacologically and demonstrates the potential of therapies that target STING for the treatment of autoinflammatory disease.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41586-018-0287-8

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Cited by

See all 1,178

Metadata

Authors
Haag, S. M., Gulen, M. F., Reymond, L., Gibelin, A., Abrami, L., Decout, A., Heymann, M., van der Goot, F. G., Turcatti, G., Behrendt, R., & Ablasser, A.
Affiliations
  • École Polytechnique Fédérale de Lausanne (CH)
  • Technische Universität Dresden (DE)
Corresponding author
Ablasser, Andrea
Venue
Nature
Published
2018-07
Volume
559
Issue
7713
Pages
269-273
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2810612816
Cited by
1,178
References
33
Citations by year
2026: 207 · 2025: 215 · 2024: 190 · 2023: 177 · 2022: 153 · 2021: 96 · 2020: 66 · 2019: 56 · 2018: 17
FWCI
25.79
Type
journal article
Language
en
Open access
Licence
  • cc-by-nc-nd
  • www.springer.com/tdm (tdm)
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
STING, small molecule inhibitors, covalent inhibitors, palmitoylation, innate immunity, autoinflammatory disease, Golgi apparatus, inflammatory cytokines, drug discovery
MeSH terms
STING Protein, Animals, Binding Sites, Cell Line, Cysteine, Golgi Apparatus, Humans, Membrane Proteins, Mice, Inbred C57BL, Protein Binding, Signal Transduction, Mice, Small Molecule Libraries, Lipoylation, Hereditary Autoinflammatory Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting STING with covalent small-molecule inhibitors. https://app.cochat.ai/papers/10.1038/s41586-018-0287-8
The paper
Haag, S. M., Gulen, M. F., Reymond, L., Gibelin, A., Abrami, L., Decout, A., Heymann, M., van der Goot, F. G., Turcatti, G., Behrendt, R., & Ablasser, A. (2018). Targeting STING with covalent small-molecule inhibitors. Nature. https://doi.org/10.1038/s41586-018-0287-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.